May 10, 2026 The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial
May 8, 2026 FDA Authorizes Additional Bivalent Boosters for Seniors and Immunocompromised Individuals